Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process

Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process

Abstract Angiogenesis is a vital biological process involving blood vessels forming from pre-existing vascular systems. This process contributes to various physiological activities, including embryonic development, hair growth, ovulation, menstruation, and the repair and regeneration of damaged tiss...

Full description

Bibliographic Details
Main Authors:	Ahmad Hoseinzadeh, Hamed Ghoddusi Johari, Mohammad Hossein Anbardar, Lobat Tayebi, Ehsan Vafa, Milad Abbasi, Ahmad Vaez, Ali Golchin, Ali Mohammad Amani, Ali Jangjou
Format:	Article
Language:	English
Published:	BMC 2022-11-01
Series:	European Journal of Medical Research
Subjects:	Vascularization Angiogenesis Anti-angiogenic therapy Nanoparticles Therapeutic applications
Online Access:	https://doi.org/10.1186/s40001-022-00833-6

Similar Items

Moving beyond nanotechnology to uncover a glimmer of hope in diabetes medicine: Effective nanoparticle-based therapeutic strategies for the management and treatment of diabetic foot ulcers
by: Hosseinzadeh, Ahmad, et al.
Published: (2023)

Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
by: Luka Roškar, et al.
Published: (2021-12-01)

Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models
by: Shuang He, et al.
Published: (2022-01-01)

Homeostatic Regulation of Pro-Angiogenic and Anti-Angiogenic Proteins via Hedgehog, Notch Grid, and Ephrin Signaling in Tibial Dyschondroplasia
by: Shah Nawaz, et al.
Published: (2023-12-01)

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
by: Changyu Yao, et al.
Published: (2023-01-01)

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
by: Lei Wang, et al.
Published: (2024-01-01)

Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
by: Wioletta Olejarz, et al.
Published: (2020-08-01)

Anti-Angiogenic Activity of Drugs in Multiple Myeloma
by: Ilaria Saltarella, et al.
Published: (2023-03-01)

Significance of anti-angiogenic therapy in head and neck cancer—Heterogeneity of tumor endothelium
by: Kyoko Hida, et al.
Published: (2010-02-01)

Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study
by: Hangfei Fu, et al.
Published: (2017-03-01)

Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer
by: Panagiotis Ntellas, et al.
Published: (2020-10-01)

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
by: Yingying Li, et al.
Published: (2022-03-01)

Time to conquer fungal infectious diseases: employing nanoparticles as powerful and versatile antifungal nanosystems against a wide variety of fungal species
by: Jangjou, Ali, et al.
Published: (2022)

Nonlinear Adaptive Optimal Controller Design for Anti-Angiogenic Tumor Treatment
by: Nitendra Nath, et al.
Published: (2023-02-01)

Extracellular Vesicles’ Role in Angiogenesis and Altering Angiogenic Signaling
by: Maryam Ateeq, et al.
Published: (2024-01-01)

Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
by: Daniela S. Ardelean, et al.
Published: (2015-02-01)

An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential
by: Nurul Akmaryanti Abdullah, et al.
Published: (2021-02-01)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
by: Lars M. Schiffmann, et al.
Published: (2022-05-01)

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma
by: Stephane Oudard, et al.
Published: (2021-12-01)

Metamorphic Effect of Angiogenic Switch in Tumor Development: Conundrum of Tumor Angiogenesis Toward Progression and Metastatic Potential
by: Daniel Leon Moshe, et al.
Published: (2023-07-01)

HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies
by: Serena Contarelli, et al.
Published: (2020-11-01)

Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine
by: Chao Mei, et al.
Published: (2023-03-01)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
by: Brigida Anna Maiorano, et al.
Published: (2022-10-01)

Insights into the angiogenic effects of nanomaterials: mechanisms involved and potential applications
by: Wenjing Liu, et al.
Published: (2020-01-01)

Anti-angiogenic therapy for glioma: Puzzle and hope
by: Zhong-ping Chen
Published: (2019-01-01)

The need for smart materials in an expanding smart world: MXene-based wearable electronics and their advantageous applications
by: Mohammad Amani, Ali, et al.
Published: (2023)

The Need for Smart Materials in an Expanding Smart World: MXene-Based Wearable Electronics and Their Advantageous Applications
by: Ali Mohammad Amani, et al.
Published: (2023-12-01)

Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis
by: Monica S. Chung, et al.
Published: (2022-04-01)

Circulating Angiogenic Factors and Ischemic Diabetic Foot Syndrome Advancement—A Pilot Study
by: Martyna Schönborn, et al.
Published: (2023-05-01)

Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
by: Filipa Lopes-Coelho, et al.
Published: (2021-04-01)

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
by: Erna-Elise Paulsen, et al.
Published: (2023-04-01)

Rola angiogenezy w rozwoju nowotworów
by: Paweł Sadłecki, et al.
Published: (2010-02-01)

Therapeutic approaches for corneal neovascularization
by: Sepehr Feizi, et al.
Published: (2017-12-01)

Alterations of plasma nitric oxide, vascular endothelial growth factor, and soluble form of its receptor (sFlt-1) after resistance exercise: An experimental study
by: Parivash Shekarchizadeh Esfahanni, et al.
Published: (2014-01-01)

Functionalized nanoceria exhibit improved angiogenic properties
by: Nethi, Susheel Kumar, et al.
Published: (2020)

Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia
by: Christy Wing Tung Wong, et al.
Published: (2022-08-01)

Models including preoperative plasma levels of angiogenic factors, leptin and IL-8 as potential biomarkers of endometrial cancer
by: Luka Roškar, et al.
Published: (2022-11-01)

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis
by: Yousef Veisani, et al.
Published: (2019-01-01)

Metabolic Syndrome and its Part in Angiogenic Cochleovestibulopathy Development
by: N. I. Ukhankova
Published: (2012-06-01)

Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy
by: Iris Uribesalgo, et al.
Published: (2019-08-01)